Company news

Cyclopharm Limited news in 2016

Cyclopharm Limited's news releases, calls and decks from 2016, newest first.

View company

CYC Achieves USFDA Agreement For Technegas Trial Design

November 23, 2016

Cyclopharm Business Update on Significant Milestones

October 12, 2016

Appendix 4D and Half Year Accounts

August 19, 2016

CYC Signs Agreement with the Canadian Association of Nuc Med

June 27, 2016

Trading Update & Record Technegas Order Received from China

June 21, 2016

Cyclopharm to Proceed Independently with FDA Trials

May 10, 2016

Cyclopharm Files Claim Against ANSTO

March 30, 2016

Trading Update

March 30, 2016

Renounceable Rights Issue and Sale of Unmarketable Parcels

March 30, 2016

Renewal of Debt Facility with National Australia Bank

March 30, 2016

Regulatory Approval in China

March 30, 2016

Clinical Protocol Approval from US FDA

March 30, 2016

Offer Booklet for Renounceable Rights Issue

March 30, 2016

Technegas COPD Trial Update

February 11, 2016

Update on Cyclotron Facility

February 10, 2016

Technegas May Facilitate Earlier Diagnosis of COPD

February 10, 2016

Technegas Clinical Trial - First Patient Enrolled

February 10, 2016

Results of Mediation

February 10, 2016

Renounceable Issue

February 10, 2016

Offer Booklet

February 10, 2016

Japanese Regulatory Approval received

February 10, 2016

Cyclotron Facility Suffers Significant Water Damage

February 10, 2016

Cyclopharm to Establish Operations in Queensland

February 10, 2016

Cyclopharm to cease Cyclotron commercial operations

February 10, 2016

Cyclopharm signs Term Sheet with Jubilant Draximage

February 10, 2016

Cyclopharm receives insurance settlement

February 10, 2016

Cyclopharm Receives Approval from United States FDA

February 10, 2016

Cyclopharm Develops New Nuclear Medicine Technology

February 10, 2016

Decks in 2016